Methylphenidate denied access to the WHO List of Essential Medicines for the second time

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Adgang til dokumentet

@article{e1d232c98f8e4331a4ad266d446dfbc0,

title = "Methylphenidate denied access to the WHO List of Essential Medicines for the second time",

keywords = "Drugs, Essential, Humans, Methylphenidate/therapeutic use, World Health Organization",

author = "Ribeiro, {Johanne Pereira} and Charlotte Lunde and Christian Gluud and Erik Simonsen and Storeb{\o}, {Ole Jakob}",

year = "2023",

month = apr,

doi = "10.1136/bmjebm-2021-111862",

language = "English",

volume = "28",

pages = "75--77",

journal = "BMJ evidence-based medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "2",

}

TY - JOUR

T1 - Methylphenidate denied access to the WHO List of Essential Medicines for the second time

AU - Ribeiro, Johanne Pereira

AU - Lunde, Charlotte

AU - Gluud, Christian

AU - Simonsen, Erik

AU - Storebø, Ole Jakob

PY - 2023/4

Y1 - 2023/4

KW - Drugs, Essential

KW - Humans

KW - Methylphenidate/therapeutic use

KW - World Health Organization

U2 - 10.1136/bmjebm-2021-111862

DO - 10.1136/bmjebm-2021-111862

M3 - Article

C2 - 35184036

SN - 2515-446X

VL - 28

SP - 75

EP - 77

JO - BMJ evidence-based medicine

JF - BMJ evidence-based medicine

IS - 2

ER -